These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 39046443)
1. YAP/TAZ enhances P-body formation to promote tumorigenesis. Shen X; Peng X; Guo Y; Dai Z; Cui L; Yu W; Liu Y; Liu CY Elife; 2024 Jul; 12():. PubMed ID: 39046443 [TBL] [Abstract][Full Text] [Related]
2. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells. Li S; Li X; Yang YB; Wu SF Apoptosis; 2024 Aug; 29(7-8):1198-1210. PubMed ID: 38553612 [TBL] [Abstract][Full Text] [Related]
3. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949 [TBL] [Abstract][Full Text] [Related]
4. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells. Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184 [TBL] [Abstract][Full Text] [Related]
5. The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer. Patterson MR; Cogan JA; Cassidy R; Theobald DA; Wang M; Scarth JA; Anene CA; Whitehouse A; Morgan EL; Macdonald A Nat Commun; 2024 Jul; 15(1):5809. PubMed ID: 38987584 [TBL] [Abstract][Full Text] [Related]
6. HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity. Yuan B; Liu J; Shi A; Cao J; Yu Y; Zhu Y; Zhang C; Qiu Y; Luo H; Shi J; Cao X; Xu P; Shen L; Liang T; Zhao B; Feng XH EMBO J; 2023 Feb; 42(4):e111549. PubMed ID: 36598329 [TBL] [Abstract][Full Text] [Related]
7. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells. Fu J; Liu W; Liu S; Zhao R; Hayashi T; Zhao H; Xiang Y; Mizuno K; Hattori S; Fujisaki H; Ikejima T Cell Signal; 2024 Jul; 119():111186. PubMed ID: 38643945 [TBL] [Abstract][Full Text] [Related]
9. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762 [TBL] [Abstract][Full Text] [Related]
10. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth. Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627 [TBL] [Abstract][Full Text] [Related]
11. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer. Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858 [TBL] [Abstract][Full Text] [Related]
12. YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation. Damkham N; Lorthongpanich C; Klaihmon P; Lueangamornnara U; Kheolamai P; Trakarnsanga K; Issaragrisil S Stem Cell Res Ther; 2022 Sep; 13(1):467. PubMed ID: 36076260 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration. Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053 [TBL] [Abstract][Full Text] [Related]
15. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer. Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196 [TBL] [Abstract][Full Text] [Related]
16. Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass. Choi S; Kang JG; Tran YTH; Jeong SH; Park KY; Shin H; Kim YH; Park M; Nahmgoong H; Seol T; Jeon H; Kim Y; Park S; Kim HJ; Kim MS; Li X; Bou Sleiman M; Lee E; Choi J; Eisenbarth D; Lee SH; Cho S; Moore DD; Auwerx J; Kim IY; Kim JB; Park JE; Lim DS; Suh JM Nat Metab; 2024 May; 6(5):847-860. PubMed ID: 38811804 [TBL] [Abstract][Full Text] [Related]
17. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682 [TBL] [Abstract][Full Text] [Related]
18. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073 [TBL] [Abstract][Full Text] [Related]
19. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
20. YAP/TAZ-mediated regulation of laminin 332 is enabled by β4 integrin repression of ZEB1 to promote ferroptosis resistance. Goel HL; Karner ER; Kumar A; Mukhopadhyay D; Goel S; Mercurio AM J Biol Chem; 2024 Apr; 300(4):107202. PubMed ID: 38508310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]